JP2023516924A5 - - Google Patents

Info

Publication number
JP2023516924A5
JP2023516924A5 JP2022550773A JP2022550773A JP2023516924A5 JP 2023516924 A5 JP2023516924 A5 JP 2023516924A5 JP 2022550773 A JP2022550773 A JP 2022550773A JP 2022550773 A JP2022550773 A JP 2022550773A JP 2023516924 A5 JP2023516924 A5 JP 2023516924A5
Authority
JP
Japan
Prior art keywords
kda
hyaluronic acid
complex
polysaccharide
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022550773A
Other languages
English (en)
Japanese (ja)
Other versions
JP7823893B2 (ja
JP2023516924A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/051558 external-priority patent/WO2021171206A1/en
Publication of JP2023516924A publication Critical patent/JP2023516924A/ja
Publication of JP2023516924A5 publication Critical patent/JP2023516924A5/ja
Application granted granted Critical
Publication of JP7823893B2 publication Critical patent/JP7823893B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022550773A 2020-02-24 2021-02-24 グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法 Active JP7823893B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062980635P 2020-02-24 2020-02-24
US62/980,635 2020-02-24
PCT/IB2021/051558 WO2021171206A1 (en) 2020-02-24 2021-02-24 Methods for enhancing transdermal delivery of glycosaminoglycans (gags)

Publications (3)

Publication Number Publication Date
JP2023516924A JP2023516924A (ja) 2023-04-21
JP2023516924A5 true JP2023516924A5 (https=) 2024-02-22
JP7823893B2 JP7823893B2 (ja) 2026-03-04

Family

ID=77491814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550773A Active JP7823893B2 (ja) 2020-02-24 2021-02-24 グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法

Country Status (4)

Country Link
US (1) US20230149683A1 (https=)
EP (1) EP4110284A4 (https=)
JP (1) JP7823893B2 (https=)
WO (1) WO2021171206A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2947097A1 (es) * 2022-02-01 2023-08-01 Martinez Miguel Angel Gomariz Metodo cosmetico de rejuvenecimiento de la piel
US20250017817A1 (en) * 2023-07-10 2025-01-16 John F. Warlick Acoustic shock wave treatment and devices for excess, sagging skin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422525D0 (en) * 2004-10-11 2004-11-10 Luebcke Peter Dermatological compositions and methods
US20170361130A9 (en) * 2008-05-23 2017-12-21 Pankaj Modi Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
CH705713B1 (de) * 2012-09-21 2013-05-15 Labo Cosprophar Ag Dermokosmetische Zusammensetzung zur topischen Anwendung.
DK3446742T3 (da) * 2013-03-15 2023-09-04 Carewear Corp Lysterapienhed
KR102540969B1 (ko) * 2015-04-01 2023-06-09 주식회사 파마리서치 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물
KR101693753B1 (ko) * 2015-06-01 2017-01-06 서울과학기술대학교 산학협력단 pH 민감성 하이드록시에틸셀룰로오스-히알루론산 복합 하이드로젤 및 그 제조방법
ES2971884T3 (es) * 2016-10-17 2024-06-10 Pola Chem Ind Inc Partículas compuestas que incluyen polímero aniónico y polímero catiónico o péptido, y método para producir partículas compuestas
CN106726430B (zh) * 2017-01-24 2023-08-29 北京欧扬医疗美容门诊部有限公司 一种基于聚焦超声技术的六层抗衰设备
US11241374B2 (en) * 2018-06-28 2022-02-08 Johnson & Johnson Consumer Inc. Compositions and methods for treating skin conditions using light and glucosamine hydrochloride
JP2021095361A (ja) * 2019-12-17 2021-06-24 ロレアル ヒアルロン酸系ポリイオンコンプレックス粒子を含む組成物

Similar Documents

Publication Publication Date Title
Maiti et al. Polysaccharide carriers for drug delivery
JP2023516924A5 (https=)
JP2011522879A5 (https=)
TWI683674B (zh) 具有改良抗性之多糖軟組織充填劑
CN101501075B (zh) 支化透明质酸和制造方法
MXPA04002217A (es) Derivados de glucosaminoglucanas parcialmente desulfatados como inhibidores de heparanasa, dotados con actividad antiangiogenica y libres de efectos anticoagulantes.
CN105979968A (zh) 具有持久性的透明质酸凝胶组合物
WO2021077681A1 (zh) 一种用于水光注射的透明质酸凝胶组合物及其制备方法
AU2001252180A1 (en) Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals
JP7730323B2 (ja) 高分子量美容組成物
CN119731257A (zh) 用于软组织填充的水凝胶
JP6132302B2 (ja) 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体
CN104703583A (zh) 经修饰的透明质酸衍生物及其用途
JP2024527398A5 (https=)
CN104125964B (zh) 部分解聚的糖胺聚糖银盐和金盐
US10463628B2 (en) Glycosaminoglycan-coated metallic nanoparticles and uses thereof
JP6561133B2 (ja) 生体適合性組成物及びこの製造方法
JP2015507070A5 (https=)
CN116617154A (zh) 含酸性基团生物材料的高效透皮递送系统
JP7823893B2 (ja) グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法
JP7569059B2 (ja) 皮膚外用剤
JP5083493B2 (ja) 保湿剤、並びに、それを用いた皮膚外用剤
Beatini et al. “REAL LIFE” efficacy evaluation of a new hyaluronic acid gel suitable for deep hydration and fine wrinkles correction
CN113271988A (zh) 酰胺交联水凝胶的交联后部分降解
JP2023182364A5 (https=)